Funding good until well past Phase IIa results, proven results on using substituted 8-quinolinols for treatment of AD, exceptional metal chelation agents, PBT2 improvement on PBT1, then onto the possibility of treating Parkinsons and others.
Looking to top up, good luck.
- Forums
- ASX - By Stock
- looking good
ATH
alterity therapeutics limited
Add to My Watchlist
10.0%
!
0.9¢

Funding good until well past Phase IIa results, proven results...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $91.27M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 0.9¢ | $1.235K | 125K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
48 | 17502845 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 3340055 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
47 | 17182845 | 0.009 |
17 | 9744798 | 0.008 |
16 | 10257963 | 0.007 |
12 | 7003518 | 0.006 |
6 | 3460001 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 3340055 | 7 |
0.011 | 21109794 | 22 |
0.012 | 15231490 | 26 |
0.013 | 6278030 | 12 |
0.014 | 12798180 | 7 |
Last trade - 10.00am 02/07/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online